Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
K V Pharma CL B (KVB)
K V Pharma CL B (KVB) Actualités

KVB

K V Pharma CL B (KVB)

K V Pharma CL B

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:KVB

1 2 3 4 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
18/06/2012	15h04	Dow Jones News	U.S. HOT STOCK FUTURES: HOT STOCKS to WATCH	NYSE:KVB	K V Pharma CL B
17/11/2011	02h15	Business Wire	Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
03/11/2011	02h40	Business Wire	Law Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
01/11/2011	02h30	Business Wire	Glancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
28/10/2011	22h30	Business Wire	Faruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
24/10/2011	19h52	Business Wire	The Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical Company	NYSE:KVB	K V Pharma CL B
13/06/2011	14h00	PR Newswire (US)	K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference Call	NYSE:KVB	K V Pharma CL B
01/04/2011	21h08	Dow Jones News	UPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid Outcry	NYSE:KVB	K V Pharma CL B
01/04/2011	16h28	Dow Jones News	K-V Pharma Slashes Prices Of Preterm Labor Drug After FDA Move	NYSE:KVB	K V Pharma CL B
31/03/2011	23h28	Dow Jones News	Religious Groups Urge Drug Makers To Ease Up On Price Hikes	NYSE:KVB	K V Pharma CL B
30/03/2011	21h58	Dow Jones News	UPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVB	K V Pharma CL B
30/03/2011	18h38	Dow Jones News	K-V Pharma Shares Drop On FDA Statement On Preterm Birth Drug	NYSE:KVB	K V Pharma CL B
01/03/2011	14h49	PR Newswire (US)	K-V Pharmaceutical Company Announces $200 Million Private Debt Offering	NYSE:KVB	K V Pharma CL B
14/02/2011	16h34	PR Newswire (US)	K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to Issue	NYSE:KVB	K V Pharma CL B
14/02/2011	15h48	PR Newswire (US)	K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common Stock	NYSE:KVB	K V Pharma CL B
04/02/2011	14h40	PR Newswire (US)	K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011	NYSE:KVB	K V Pharma CL B
12/01/2011	15h03	PR Newswire (US)	K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™	NYSE:KVB	K V Pharma CL B
14/09/2010	16h29	Dow Jones News	K-V Pharmaceutical Enters Loan Agreement In Wake Of FDA Approval	NYSE:KVB	K V Pharma CL B
10/09/2010	15h53	Dow Jones News	K-V Pharma Soars On FDA Approval To Return Product To Market	NYSE:KVB	K V Pharma CL B
20/01/2010	21h41	Dow Jones News	UPDATE: Watson Pharma Benefits From Toprol Market Presence	NYSE:KVB	K V Pharma CL B
20/01/2010	20h11	Dow Jones News	Watson Pharma Continues To Benefit From Toprol Market Presence	NYSE:KVB	K V Pharma CL B
11/01/2010	15h18	PR Newswire (US)	KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)	NYSE:KVB
07/01/2010	22h10	PR Newswire (US)	KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of Director	NYSE:KVB
15/12/2009	23h26	PR Newswire (US)	KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent	NYSE:KVB
02/12/2009	22h45	PR Newswire (US)	KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van Vliet	NYSE:KVB
13/11/2009	22h01	PR Newswire (US)	KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw Amendments	NYSE:KVB
07/10/2009	19h54	Dow Jones News	Large Generic Drug Cos Benefiting From Price Stability	NYSE:KVB	K-V Pharmaceutical Co. (Cl B)
21/09/2009	14h30	PR Newswire (US)	KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)	NYSE:KVB
15/09/2009	22h34	PR Newswire (US)	KV Pharmaceutical Receives Stockholder Action by Written Consent	NYSE:KVB
04/09/2009	23h43	PR Newswire (US)	KV Pharmaceutical Appoints Interim Chief Financial Officer	NYSE:KVB

Showing the most relevant articles for your search:NYSE:KVB

1 2 3 4 Suivant >>

Siemens Fin Tf 2,875% Mz...

Republic of France

First Trust Exchange Tra...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales